Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys
Open Access
- 2 October 2003
- Vol. 315 (2) , 345-352
- https://doi.org/10.1016/s0042-6822(03)00542-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccineGene Therapy, 2001
- Response of human monocyte-derived dendritic cells to immunostimulatory DNAEuropean Journal of Immunology, 2000
- Japanese Encephalitis and Dengue VaccinesBiologicals, 1997
- Yellow Fever VaccinesBiologicals, 1997
- Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virusArchiv für die gesamte Virusforschung, 1996
- Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical TrialsHuman Gene Therapy, 1995
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- Evaluation of vero cell lysate antigen for the ELISA of flavivirusesJournal of Clinical Laboratory Analysis, 1993
- Dengue 2 Virus Envelope Protein Expressed by a Recombinant Vaccinia Virus Fails to Protect Monkeys against DengueJournal of General Virology, 1988
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988